Haleon

HLN - HaleonDividends

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon’s brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

See below the complete and updated table with all dividends paid and declared history, etc

Excluding DateValue (U$)Frequency
8/14/2026
0,064
Biannual
4/10/2026
0,133
Biannual
8/15/2025
0,06
Biannual
4/25/2025
0,125
Biannual
8/16/2024
0,053
Biannual
3/14/2024
0,105
Biannual
8/24/2023
0,044
Biannual
3/16/2023
0,06
Biannual

The latest dividend from HLN was $0.064 per share (ex-dividend 8/14/2026). The dividend yield over the last 12 months is 2%. Over the last 12 months there were 2 distributions, totalling $0.198 per share.